Black Rock Inc. Ironwood Pharmaceuticals Inc Transaction History
Black Rock Inc.
- $4.35 Trillion
- Q2 2024
A detailed history of Black Rock Inc. transactions in Ironwood Pharmaceuticals Inc stock. As of the latest transaction made, Black Rock Inc. holds 22,877,015 shares of IRWD stock, worth $22.4 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
22,877,015
Previous 24,157,768
5.3%
Holding current value
$22.4 Million
Previous $210 Million
29.11%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding IRWD
# of Institutions
176Shares Held
159MCall Options Held
11.2MPut Options Held
0-
Vanguard Group Inc Valley Forge, PA16.2MShares$15.9 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY16.2MShares$15.8 Million0.2% of portfolio
-
Sarissa Capital Management LP Greenwich, CT15.9MShares$15.6 Million8.54% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny8.41MShares$8.24 Million0.01% of portfolio
-
Acadian Asset Management LLC Boston, MA6.55MShares$6.42 Million0.01% of portfolio
About IRONWOOD PHARMACEUTICALS INC
- Ticker IRWD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 153,231,008
- Market Cap $150M
- Description
- Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...